Except the cost of many drugs continues to go up, even as they're commercially available and R&D has been recouped

Yes, it is a bucket. I would like your examples though.

We already lower the costs of a lot of drug design by doing (some of) it at public universities.

Yes, we should do this more. Public funding is very rarely sufficient to go through the whole development -> market process.